Cargando…
Can Aspirin Minimize Stroke Risk and New Lesion Formation in Multiple Sclerosis?
Even with increasing data implicating the venous side of the vascular tree of the brain in MS, no diagnostic or treatment protocol has addressed the risk of acute stroke in MS and no systematic study has documented the incidence or prevalence of acute strokein MS patients. Approximately 795,000 stro...
Autores principales: | Avasarala, Jagannadha, Parti, Naveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092498/ https://www.ncbi.nlm.nih.gov/pubmed/30135678 http://dx.doi.org/10.3389/fneur.2018.00613 |
Ejemplares similares
-
Anti-CD20 Cell Therapies in Multiple Sclerosis—A Fixed Dosing Schedule for Ocrelizumab is Overkill
por: Avasarala, Jagannadha
Publicado: (2017) -
Analysis of NAMCS data for multiple sclerosis, 1998–2004
por: Avasarala, Jagannadha R, et al.
Publicado: (2007) -
An Overview of Venous Abnormalities Related to the Development of Lesions in Multiple Sclerosis
por: Haacke, E. Mark, et al.
Publicado: (2021) -
ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis
por: Kever, Anne, et al.
Publicado: (2020) -
Some Spinal Cord Lesions.—III: Insular, Multiple, or Disseminate Sclerosis
Publicado: (1911)